News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Henn Matthew R.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/01/2023 |
4
| Henn Matthew R. (See Remarks) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $10.84, valued at
$379.4k
|
|
| 02/07/2023 |
4
| Henn Matthew R. (See Remarks) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 45,000 restricted stock units
@ $0
Granted 90,000 options to buy
@ $5.5, valued at
$495k
|
|
| 09/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2020 |
4
| Henn Matthew R. (See Remarks) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Sold 55,706 shares
@ $26.56, valued at
$1.5M
Sold 26,265 shares
@ $27.56, valued at
$723.9k
Sold 9,841 shares
@ $28.34, valued at
$278.9k
Exercised 26,000 options to buy
@ $0.71, valued at
$18.5k
Exercised 26,250 options to buy
@ $9.89, valued at
$259.6k
Exercised 27,562 options to buy
@ $6.01, valued at
$165.6k
|
|
| 01/31/2020 |
4
| Henn Matthew R. (See Remarks) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $3.3, valued at
$990k
|
|
| 01/28/2020 |
4
| Henn Matthew R. (See Remarks) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Exercised 7,500 restricted stock units
@ $0 |
|
|
|